Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Capital Expenditures (2019 - 2025)

Inventiva (IVEVF) posted Capital Expenditures of -$64521.7 for Q2 2025, up 76.5% on a QoQ basis from -$274606.3 in Q2 2024, and up 76.5% year-over-year from -$36555.4 in Q2 2024.

Analysis

Inventiva (IVEVF) Capital Expenditures (2019 - 2025) Analysis & Trends

Inventiva has reported Capital Expenditures for 5 years, with the latest figure at -$64521.7 in Q2 2025.

  • On a quarterly basis, Capital Expenditures rose 76.5% year-over-year to -$64521.7 in Q2 2025; TTM through Jun 2025 was -$949979.4, a 10.9% increase from a year earlier, with the FY2025 full-year figure at -$287518.7, up 19.2% from the prior year.
  • Capital Expenditures was -$64521.7 for Q2 2025 at Inventiva, up from -$274606.3 in the prior quarter.
  • The five-year high for Capital Expenditures was -$49455.7 in Q1 2021, with the low at -$308858.1 in Q3 2022.
  • Average Capital Expenditures over 4 years is -$188726.0, with a median of -$180747.4 recorded in 2021.
  • The sharpest annual moves came in 2022 and 2025: Capital Expenditures plunged 67.08% in 2022, then jumped 76.5% in 2025.
  • Over 4 years, Capital Expenditures stood at -$180747.4 in 2021, then slumped by 67.08% to -$301993.2 in 2022, then rose by 9.07% to -$274606.3 in 2024, then surged by 76.5% to -$64521.7 in 2025.
  • The last three Capital Expenditures figures came in at -$64521.7 (Q2 2025), -$274606.3 (Q2 2024), and -$301993.2 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 1.32 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 322.00 Mn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn -321.00 Mn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 533.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.19 Bn 44.19 Bn - 2.29 Mn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 12.41 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 108.00 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -64,521.70
Jun 30, 2024 -274,606.33
Dec 31, 2022 -301,993.22
Sep 22, 2022 -308,858.12
Dec 31, 2021 -180,747.41
Jun 30, 2021 -140,899.76
Mar 31, 2021 -49,455.68
Dec 31, 2019 -161,605.60